Faithful animal modelling of human glioma by using primary initiating cells and its implications for radiosensitization therapy [ARRIVE 1]
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Faithful animal modelling of human glioma by using primary initiating cells and its implications for radiosensitization therapy [ARRIVE 1]
Authors
Keywords
-
Journal
Scientific Reports
Volume 8, Issue 1, Pages -
Publisher
Springer Nature America, Inc
Online
2018-09-17
DOI
10.1038/s41598-018-32578-w
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Overcoming therapeutic resistance in glioblastoma: the way forward
- (2017) Satoru Osuka et al. JOURNAL OF CLINICAL INVESTIGATION
- Convection-enhanced delivery in glioblastoma: a review of preclinical and clinical studies
- (2017) Arman Jahangiri et al. JOURNAL OF NEUROSURGERY
- Life beyond a diagnosis of glioblastoma: a systematic review of the literature
- (2017) L Gately et al. Journal of Cancer Survivorship
- Advances in drug delivery to high grade gliomas
- (2016) Guido Frosina BRAIN PATHOLOGY
- Nanoparticle-mediated drug delivery to high-grade gliomas
- (2016) Guido Frosina Nanomedicine-Nanotechnology Biology and Medicine
- Origin of the U87MG glioma cell line: Good news and bad news
- (2016) Marie Allen et al. Science Translational Medicine
- Mechanisms of ATM Activation
- (2015) Tanya T. Paull Annual Review of Biochemistry
- Selective Inhibition of Parallel DNA Damage Response Pathways Optimizes Radiosensitization of Glioblastoma Stem-like Cells
- (2015) S. U. Ahmed et al. CANCER RESEARCH
- Pharmacokinetics, pharmacodynamics and efficacy on pediatric tumors of the glioma radiosensitizer KU60019
- (2014) Donatella Vecchio et al. INTERNATIONAL JOURNAL OF CANCER
- EANO guideline for the diagnosis and treatment of anaplastic gliomas and glioblastoma
- (2014) Michael Weller et al. LANCET ONCOLOGY
- Abrogation of radioresistance in glioblastoma stem-like cells by inhibition of ATM kinase
- (2014) Ross Carruthers et al. Molecular Oncology
- ATM Kinase Inhibition Preferentially Sensitizes p53-Mutant Glioma to Ionizing Radiation
- (2013) L. Biddlestone-Thorpe et al. CLINICAL CANCER RESEARCH
- Predictability, efficacy and safety of radiosensitization of glioblastoma-initiating cells by the ATM inhibitor KU-60019
- (2013) Donatella Vecchio et al. INTERNATIONAL JOURNAL OF CANCER
- Characterization of Glioma Stem Cells Through Multiple Stem Cell Markers and Their Specific Sensitization to Double-Strand Break-Inducing Agents by Pharmacological Inhibition of Ataxia Telangiectasia Mutated Protein
- (2012) Alessandro Raso et al. BRAIN PATHOLOGY
- Dynamic inhibition of ATM kinase provides a strategy for glioblastoma multiforme radiosensitization and growth control
- (2012) Sarah E. Golding et al. CELL CYCLE
- Epidemiology of glial and non-glial brain tumours in Europe
- (2012) Emanuele Crocetti et al. EUROPEAN JOURNAL OF CANCER
- Improving Bioscience Research Reporting: The ARRIVE Guidelines for Reporting Animal Research
- (2010) Carol Kilkenny et al. PLOS BIOLOGY
- Comparative Analysis of DNA Repair in Stem and Nonstem Glioma Cell Cultures
- (2009) M. Ropolo et al. MOLECULAR CANCER RESEARCH
- DNA Repair and Resistance of Gliomas to Chemotherapy and Radiotherapy
- (2009) G. Frosina MOLECULAR CANCER RESEARCH
- Improved ATM kinase inhibitor KU-60019 radiosensitizes glioma cells, compromises insulin, AKT and ERK prosurvival signaling, and inhibits migration and invasion
- (2009) S. E. Golding et al. MOLECULAR CANCER THERAPEUTICS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started